NeoGenomics Inc (NEO)

NASDAQ
12.91
+0.29(+2.30%)
After Hours
13.00
+0.09(+0.70%)
- Real-time Data
  • Volume:
    1,727,554
  • Day's Range:
    12.45 - 12.98
  • 52 wk Range:
    6.85 - 54.74

NEO Overview

Prev. Close
12.62
Day's Range
12.45-12.98
Revenue
489.31M
Open
12.66
52 wk Range
6.85-54.74
EPS
-1.19
Volume
1,727,554
Market Cap
1.62B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,948,051
P/E Ratio
-10.41
Beta
0.935
1-Year Change
-70.31%
Shares Outstanding
125,795,904
Next Earnings Date
Nov 01, 2022
What is your sentiment on NeoGenomics?
or
Market is currently closed. Voting is open during market hours.

NeoGenomics Inc Analysis

NeoGenomics Inc Company Profile

NeoGenomics Inc Company Profile

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • Great discout! Just bought more
    0